Widespread Use of Measurable Residual Disease in Acute Myeloid Leukemia Practice

被引：0
|
作者：
Epstein-Peterson, Zachary D.
Devlin, Sean M.
Stein, Eytan M.
Estey, Elihu H.
Tallman, Martin S.
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5103
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Widespread use of measurable residual disease in acute myeloid leukemia practice
    Epstein-Peterson, Zachary D.
    Devlin, Sean M.
    Stein, Eytan M.
    Estey, Elihu
    Tallman, Martin S.
    LEUKEMIA RESEARCH, 2018, 67 : 92 - 98
  • [2] Clinical Use of Measurable Residual Disease in Acute Myeloid Leukemia
    Roug, Anne Stidsholt
    Ommen, Hans Beier
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2019, 20 (04)
  • [3] Clinical Use of Measurable Residual Disease in Acute Myeloid Leukemia
    Anne Stidsholt Roug
    Hans Beier Ommen
    Current Treatment Options in Oncology, 2019, 20
  • [4] Evaluating measurable residual disease in acute myeloid leukemia
    Ravandi, Farhad
    Walter, Roland B.
    Freeman, Sylvie D.
    BLOOD ADVANCES, 2018, 2 (11) : 1356 - 1366
  • [5] Perspective on measurable residual disease testing in acute myeloid leukemia
    Walter, Roland B.
    LEUKEMIA, 2024, 38 (01) : 10 - 13
  • [6] Clinical Impact of Measurable Residual Disease in Acute Myeloid Leukemia
    Azenkot, Tali
    Jonas, Brian A.
    CANCERS, 2022, 14 (15)
  • [7] Improved detection of measurable residual disease in acute myeloid leukemia
    Zhang, Xuan
    Grimes, H. Leighton
    SCIENCE ADVANCES, 2023, 9 (38)
  • [8] How close are we to incorporating measurable residual disease into clinical practice for acute myeloid leukemia?
    Short, Nicholas J.
    Ravandi, Farhad
    HAEMATOLOGICA, 2019, 104 (08) : 1532 - 1541
  • [9] Clonal hematopoiesis and measurable residual disease assessment in acute myeloid leukemia
    Hasserjian, Robert P.
    Steensma, David P.
    Graubert, Timothy A.
    Ebert, Benjamin L.
    BLOOD, 2020, 135 (20) : 1729 - 1738
  • [10] Prognostic and therapeutic implications of measurable residual disease in acute myeloid leukemia
    Marisa J. L. Aitken
    Farhad Ravandi
    Keyur P. Patel
    Nicholas J. Short
    Journal of Hematology & Oncology, 14
12345